Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,719
archived clinical trials in
Diabetic Neuropathy

A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Providence, RI
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Orangeburg, SC
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Orangeburg, SC
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Dallas, TX
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Lufkin, TX
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Lufkin, TX
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Suffolk, VA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Suffolk, VA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Milwaukee, WI
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
mi
from
Camperdown,
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
mi
from
Camperdown,
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Saint George, UT
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Saint George, UT
Click here to add this to my saved trials
A Pilot Study of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
A Pilot Study of Allopurinol to Prevent GFR Loss in Type 1 Diabetes.
Status: Enrolling
Updated:  12/13/2017
Joslin Diabetes Center
mi
from
Boston, MA
A Pilot Study of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
A Pilot Study of Allopurinol to Prevent GFR Loss in Type 1 Diabetes.
Status: Enrolling
Updated: 12/13/2017
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Pilot Study of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
A Pilot Study of Allopurinol to Prevent GFR Loss in Type 1 Diabetes.
Status: Enrolling
Updated:  12/13/2017
Steno Diabetes Center
mi
from
Gentofte,
A Pilot Study of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
A Pilot Study of Allopurinol to Prevent GFR Loss in Type 1 Diabetes.
Status: Enrolling
Updated: 12/13/2017
Steno Diabetes Center
mi
from
Gentofte,
Click here to add this to my saved trials
Nociceptive Pain Fiber Response
A Multi-Center, Randomized, Sham-Controlled, Double-Blind Study of Pulsed Electromagnetic Field (PEMF) Therapy to Evaluate Small Fiber Nerve Growth and Function in Subjects With Painful Peripheral Diabetic Neuropathy
Status: Enrolling
Updated:  1/10/2018
Extremity Health Center
mi
from
Scottsdale, AZ
Nociceptive Pain Fiber Response
A Multi-Center, Randomized, Sham-Controlled, Double-Blind Study of Pulsed Electromagnetic Field (PEMF) Therapy to Evaluate Small Fiber Nerve Growth and Function in Subjects With Painful Peripheral Diabetic Neuropathy
Status: Enrolling
Updated: 1/10/2018
Extremity Health Center
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
High Intensity Muscle Power and Balance Perturbation Training to Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/24/2018
PTRS Research Lab
mi
from
Baltimore, MD
Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
High Intensity Muscle Power and Balance Perturbation Training to Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/24/2018
PTRS Research Lab
mi
from
Baltimore, MD
Click here to add this to my saved trials
Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
High Intensity Muscle Power and Balance Perturbation Training to Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/24/2018
VA Maryland Health Care System
mi
from
Baltimore, MD
Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
High Intensity Muscle Power and Balance Perturbation Training to Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/24/2018
VA Maryland Health Care System
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effect of Sulodexide in Early Diabetic Nephropathy
The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria
Status: Enrolling
Updated:  2/22/2018
The Collaborative Study Group, Clinical Coordinating Center for U.S. and Canadian Clinics, Rush University Medical Center
mi
from
Chicago, IL
Effect of Sulodexide in Early Diabetic Nephropathy
The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria
Status: Enrolling
Updated: 2/22/2018
The Collaborative Study Group, Clinical Coordinating Center for U.S. and Canadian Clinics, Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Effect of Sulodexide in Early Diabetic Nephropathy
The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria
Status: Enrolling
Updated:  2/22/2018
The Collaborative Study Group, Clinical Coordinating Center for the Pacific Region, Monash Medical Center
mi
from
Melbourne,
Effect of Sulodexide in Early Diabetic Nephropathy
The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria
Status: Enrolling
Updated: 2/22/2018
The Collaborative Study Group, Clinical Coordinating Center for the Pacific Region, Monash Medical Center
mi
from
Melbourne,
Click here to add this to my saved trials
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated:  2/27/2018
Collaborative Neuroscience Network, LLC- Southland Neurologic Associates - Los Alamitos
mi
from
Garden Grove, CA
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated: 2/27/2018
Collaborative Neuroscience Network, LLC- Southland Neurologic Associates - Los Alamitos
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated:  2/27/2018
SDS Clinial Trials, Inc
mi
from
Orange, CA
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated: 2/27/2018
SDS Clinial Trials, Inc
mi
from
Orange, CA
Click here to add this to my saved trials
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated:  2/27/2018
Compass Research LLC
mi
from
Orlando, FL
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated: 2/27/2018
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated:  2/27/2018
Infinity Clinical Research, LLC
mi
from
Sunrise, FL
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated: 2/27/2018
Infinity Clinical Research, LLC
mi
from
Sunrise, FL
Click here to add this to my saved trials
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated:  2/27/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated: 2/27/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated:  2/27/2018
Nerve and Muscle Center of Texas
mi
from
Houston, TX
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated: 2/27/2018
Nerve and Muscle Center of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated:  2/27/2018
Endeavor Clinical Trials, PA
mi
from
San Antonio, TX
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated: 2/27/2018
Endeavor Clinical Trials, PA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes
Randomized Study of Antihypertensives and Antilipemics in American Indians With Non-Insulin-Dependent Diabetes Mellitus at High Risk of Developing Nephropathy and Cardiovascular Disease
Status: Enrolling
Updated:  3/5/2018
Hennepin County Medical Center
mi
from
Minneapolis, MN
Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes
Randomized Study of Antihypertensives and Antilipemics in American Indians With Non-Insulin-Dependent Diabetes Mellitus at High Risk of Developing Nephropathy and Cardiovascular Disease
Status: Enrolling
Updated: 3/5/2018
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Barbara Davis Center / University of Colorado Denver
mi
from
Aurora, CO
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Barbara Davis Center / University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Kaiser Permanente Colorado Institute for Health Research
mi
from
Denver, CO
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Kaiser Permanente Colorado Institute for Health Research
mi
from
Denver, CO
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Atlanta Diabetes Associates
mi
from
Atlanta, GA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Atlanta Diabetes Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Massachusetts General Hospital
mi
from
Boston, MA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Joslin Diabetes Center
mi
from
Boston, MA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
University of Massachusetts Memorial Health Care
mi
from
Worcester, MA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
University of Massachusetts Memorial Health Care
mi
from
Worcester, MA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Brehm Center for Diabetes Research / University of Michigan
mi
from
Ann Arbor, MI
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Brehm Center for Diabetes Research / University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Univ of Minnesota
mi
from
Minneapolis, MN
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Albert Einstein College of Medicine/ Montefiore Medical Center
mi
from
Bronx, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Albert Einstein College of Medicine/ Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Jacobi Medical Center
mi
from
Bronx, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Jacobi Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Winthrop University Hospital
mi
from
Mineola, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Virginia Mason Medical Center
mi
from
Seattle, WA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Univ of Washington
mi
from
Seattle, WA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Providence Sacred Heart Medical Center
mi
from
Spokane, WA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Providence Sacred Heart Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Henry Ford Health System
mi
from
Detroit, MI
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Weill Cornell Medical Center
mi
from
New York, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
SUNY Upstate Medical University
mi
from
Syracuse, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
University of Texas Southwestern
mi
from
Dallas, TX
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
University of Calgary
mi
from
Calgary,
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
University of Calgary
mi
from
Calgary,
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Washington University
mi
from
Saint Louis, MO
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Gunderson Health System
mi
from
La Crosse, WI
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Gunderson Health System
mi
from
La Crosse, WI
Click here to add this to my saved trials
Study of PEMF to Evaluate VPT and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy
A Multi-Center, Sham-Controlled, Double-Blind Randomized Withdrawal Study of PEMF Therapy to Evaluate Vibration Perception Threshold and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy in the Lower Extremity
Status: Enrolling
Updated:  4/9/2018
Associated Foot & Ankle Specialists, LLC
mi
from
Phoenix, AZ
Study of PEMF to Evaluate VPT and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy
A Multi-Center, Sham-Controlled, Double-Blind Randomized Withdrawal Study of PEMF Therapy to Evaluate Vibration Perception Threshold and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy in the Lower Extremity
Status: Enrolling
Updated: 4/9/2018
Associated Foot & Ankle Specialists, LLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Nephrology Associates, P.C.
mi
from
Birmingham, AL
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Nephrology Associates, P.C.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
University of Alabama
mi
from
Birmingham, AL
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials